drugset
drugset / Trial / NCT02598206

Food Effect Study PF-04136309

NCT02598206 ↗

Phase 1 Completed 18 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to evaluate the effect of food intake on PF-04136309 pharmacokinetics (PK) following a single dose at 1000 mg.

Timeline

Start
2015-12
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-4136309 Small molecule 1000 mg —

Indications

No indication recorded.